Jeff Yass’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.4K Sell
12,942
-7,708
-37% -$67.2K ﹤0.01% 12603
2026
Q2
$178K Buy
+20,650
New +$163K ﹤0.01% 12058
2025
Q4
– Sell
-2,523
Closed -$32.7K – 12190
2025
Q3
$32.7K Buy
+2,523
New +$29.7K ﹤0.01% 11962
2025
Q2
– Sell
-28,608
Closed -$346K – 12549
2025
Q1
$346K Sell
28,608
-1,247
-4% -$17.8K ﹤0.01% 9740
2024
Q4
$460K Buy
29,855
+7,084
+31% +$134K ﹤0.01% 8884
2024
Q3
$525K Buy
22,771
+6,402
+39% +$143K ﹤0.01% 8356
2024
Q2
$317K Buy
16,369
+15,187
+1,285% +$407K ﹤0.01% 9323
2024
Q1
$44.4K Sell
1,182
-965
-45% -$39.9K ﹤0.01% 11601
2023
Q4
$64.9K Buy
2,147
+1,366
+175% +$29.8K ﹤0.01% 11597
2023
Q3
$17.1K Sell
781
-1,894
-71% -$66.9K ﹤0.01% 11638
2023
Q2
$104K Sell
2,675
-4,332
-62% -$382K ﹤0.01% 10922
2023
Q1
$646K Buy
7,007
+5,849
+505% +$734K ﹤0.01% 7941
2022
Q4
$166K Sell
1,158
-2,842
-71% -$709K ﹤0.01% 10379
2022
Q3
$910K Buy
4,000
+3,318
+487% +$842K ﹤0.01% 6880
2022
Q2
$159K Buy
+682
New +$150K ﹤0.01% 10952
2022
Q1
– Sell
-2,576
Closed -$592K – 12875
2021
Q4
$721K Buy
+2,576
New +$442K ﹤0.01% 8165
2021
Q3
– Sell
-1,223
Closed -$201K – 12646
2021
Q2
$201K Sell
1,223
-4,170
-77% -$849K ﹤0.01% 11587
2021
Q1
$1.13M Buy
5,393
+3,831
+245% +$879K ﹤0.01% 7409
2020
Q4
$351K Buy
+1,562
New +$320K ﹤0.01% 8955
2020
Q3
– Sell
-149
Closed -$36K – 10468
2020
Q2
$36K Sell
149
-340
-70% -$66.8K ﹤0.01% 9827
2020
Q1
$56K Buy
489
+113
+30% +$16.8K ﹤0.01% 9621
2019
Q4
$63K Buy
+376
New +$190K ﹤0.01% 9283

Other funds holding ACET

Jeff Yass's ACET Position: Q3 2026 in Review

Jeff Yass reduced its Adicet Bio (ACET) stake by 37% in Q3 2026, selling an estimated $67.2K and leaving 12,942 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12603.

Jeff Yass first reported a position in ACET in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.13M in Q1 2021. 54 funds tracked by Wall St. Rank hold ACET as of Q3 2026.

  • Jeff Yass held 12,942 shares of Adicet Bio worth $92.4K as of Q3 2026.
  • Jeff Yass sold 7,708 Adicet Bio shares in Q3 2026, an estimated $67.2K.
  • Adicet Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12603 holding.
  • Jeff Yass first reported a position in Adicet Bio in Q4 2019 and has held it in 22 quarters since.
  • Jeff Yass's Adicet Bio position peaked at $1.13M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.